Blue Owl Capital Holdings’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1M | Hold |
1,328,351
| – | – | 3.27% | 9 |
|
|
2025
Q1 | $4.33M | Buy |
1,328,351
+4,474
| +0.3% | +$14.6K | 1.4% | 19 |
|
|
2024
Q4 | $5.96M | Sell |
1,323,877
-350,000
| -21% | -$1.58M | 1.37% | 18 |
|
|
2024
Q3 | $4.64M | Hold |
1,673,877
| – | – | 0.89% | 26 |
|
|
2024
Q2 | $5.72M | Hold |
1,673,877
| – | – | 1.59% | 18 |
|
|
2024
Q1 | $9.07M | Buy |
1,673,877
+1,318,500
| +371% | +$7.15M | 1.81% | 16 |
|
|
2023
Q4 | $1.93M | Buy |
+355,377
| New | +$1.93M | 0.46% | 30 |
|